This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Corbus Pharmaceuticals Holdings Inc. shed 7.8% to $6.96 on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index falling 2.6% to 18,350.19 and Dow Jones Industrial Average falling 1.5% to 43,191.24.
Corbus Pharmaceuticals Holdings Inc. closed 88.8% short of its 52-week high of $61.90, which the company reached on July 31st.
The stock demonstrated a mixed performance when compared to some of its competitors, as Vanda Pharmaceuticals Inc. fell 0.8% to $4.72, Fortress Biotech Inc. fell 3.2% to $1.52, and Viking Therapeutics Inc. fell 10.98% to $25.70.
Trading volume totaled 241,567, compared to the 50-day average of 272,326.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
March 03, 2025 16:33 ET (21:33 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。